Filter By Industry
Filter By Tag

Newsroom

ITCES Corporation Press releases

1 - 5 of 5 Press Releases

Weight Loss Drug Product, Obestrin® Study Begins
Mar 10, 2010
ITCES Corporation has been contracted to perform both recruitment and subsequent statistical meta-analysis in a study of the weight loss drug product, Obestrin®.

ITCES Renames AVT-12 Weight Loss Combination Drug Product, Obestrin®
Mar 05, 2010
Weight loss product renamed in readiness for market.

ITCES Releases Results of Year-Long AVT-12 Controlled Trial
Mar 05, 2010
Report on One-year Findings from Controlled Trial of AVT-12 Combination Drug Product on Weight Loss and Various Metabolic Risk Factors

AVT-12 Weight Loss Study Abstract
Mar 04, 2010
One-year Findings from Controlled Trial of AVT-12 Combination Drug Product on Weight Loss and Various Metabolic Risk Factors

AVT-12 Weight Loss Drug Product Study Concludes
Mar 03, 2010
The weight loss combination drug product, AVT-12 has most recently been the subject of a year-long phase III randomized, double-blind, placebo-controlled efficacy trial, conducted by ITCES Corporation.


ITCES Corporation RSS Feed